Research News and Updates

Read the latest from the CMT Research Foundation on drug development and clinical advances.

Shift Pharmaceuticals Completes CMT Research Foundation-Funded Project, Will Continue Development of Gene Therapy for CMT1A

By Keith Fargo, Chief Scientific Officer The CMT Research Foundation is pleased to announce that Shift Pharmaceuticals (Shift) has successfully completed their CMT Research Foundation-funded RNA-based therapy project. Shift created and tested a library of novel...

Teams at Cyprus Institute of Neurology & Genetics and Nationwide Children’s Hospital Complete CMT Research Foundation-Funded Project, Resulting Therapeutic Now Moving into Pharmaceutical Development

Update, May 17, 2022: This work is now published in The Journal of Clinical Investigation. By Keith Fargo, Ph.D., Chief Scientific Officer, CMT Research FoundationThe CMT Research Foundation is pleased to announce that Dr. Kleopas Kleopa, a renowned neuromuscular...


4062 Peachtree Road
Suite A209
Atlanta, GA 30319

Phone Number


Media Inquiries

George Simpson


[email protected]